The pro-life movement, via powerful rhetorical and legislative measures, has effectively targeted the abortion market, working to get as many death clinics shut down as possible. As a result, America’s biggest abortion mill, Planned Parenthood, has been unable to kill as many babies as they’d like; clinics are closing — seven states are down to just one abortion clinic — and the threat to fully de-fund the corrupt death mill is looming.
So, now, Planned Parenthood is looking to supplement, diversifying in the transgender hormone therapy market. Of course, it makes perfect sense that an entity responsible for over 300,000 dead babies a year would “diversify” their market by targeting another vulnerable group, those who suffer from gender dysphoria.
.png)
.png)

